With 4.27 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.7 million shares. The 52-week range on XXII shows that it touched its highest point at $243.00 and its lowest point at $0.70 during that stretch. It currently has a 1-year price target of $12.00. Beta for the stock currently stands at 1.99.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of XXII was up-trending over the past week, with a rise of 77.37%, but this was up by 20.69% over a month. Three-month performance dropped to -65.09% while six-month performance fell -89.67%. The stock lost -99.37% in the past year, while it has lost -73.63% so far this year. A look at the trailing 12-month EPS for XXII yields -518.20 with Next year EPS estimates of 1.06. For the next quarter, that number is -1.10. This implies an EPS growth rate of 97.80% for this year and 145.49% for next year.
Float and Shares Shorts:
At present, 2.37 million XXII shares are outstanding with a float of 1.75 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for XXII since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2678.4 being high and -$2678.4 being low. For XXII, this leads to a yearly average estimate of -$2678.4.
